ARAF to check information from new ARD film on doping in Russian sportSport January 22, 22:47
All countries observe oil output cuts agreement — Russian energy ministerBusiness & Economy January 22, 16:59
Rogozin calls "dangerous incident" UK botched missile launchRussian Politics & Diplomacy January 22, 16:32
Medvedev calls United Russia ruling party, president's main resourceRussian Politics & Diplomacy January 22, 16:27
Mutko calls silly information Infantino asks him not to run for RFU headSport January 22, 16:24
Seven parties to participate in Syrian talksWorld January 22, 9:54
Russia’s Pavlyuchenkova reaches Australian Open quarterfinalsSport January 22, 7:19
IBU Executive Board finds no grouns to suspend Russia's biathlon teamSport January 21, 22:53
Russia terrified watching monuments destroyed in Palmyra — culture ministerRussian Politics & Diplomacy January 21, 17:08
DARMSTADT, Germany, Jan. 27 /PRNewswire/ -- Merck Millipore, the Life Science business of Merck, today announced the introduction of its AFS® 40E / 80E / 120E and 150E water purification systems. These new systems have been developed to provide clinical laboratories with an economical and reliable water purification solution for daily water volumes of up to 3000 L.
The AFS® 40E / 80E / 120E and 150E systems rely on two powerful technologies to produce water quality meeting Clinical and Laboratory Standards Institute® (CLSI®) Clinical Laboratory Reagent Water standards. State-of-the-art, proven Elix® electrodeionization (EDI) technology ensures constant water quality with low and predictable running costs, while unique E.R.A.™ (Evolutive Reject Adjustment) technology takes feed water quality into account in order to automatically optimize water recovery - and reduce water usage costs.
"Biomedical laboratory managers are under constant pressure to avoid clinical analyzer downtime," notes John Sweeney, Head of Lab Solutions Business, Merck Millipore. "Water is the most frequently used fluidic reagent in clinical analyzers, and for labs handling thousands of samples a day, the choice of a water purification system is key to providing high-quality pure water and smooth operations," he explains. "Our new AFS® 40E / 80E / 120E and 150E systems incorporate the latest technologies, for robust and reliable performance. Our goal is to help make the biomedical lab more productive — and these AFS® E systems do exactly that."
The AFS® 40E / 80E / 120E and 150E systems also offer users powerful 24/7 real-time monitoring and remote control over their water purification systems, as well as a new generation of enhanced services. These advanced monitoring features, along with an unprecedented level of service, also help maximize water purification system and analyzer uptime.
The systems have been designed to provide quick and precise remote diagnostics and offer proactive service in order to avoid downtime. Service starts with feed water analysis by a certified Merck Millipore Field Service Engineer prior to system installation. Then, over time, users can ensure the best upkeep of their AFS® E water purification system with a customized Watercare Pact service plan.
With its large new touch screen, the system is designed for intuitive operation and for supporting the user with easy step-by-step instructions during routine maintenance. Interacting with the water purification system has never been easier. For increased flexibility, the system interface can also be accessed from another location, using a PC, tablet, or smart phone through a web browser.
Mobile and customizable, the new range of systems is designed to make the best use of lab space. The quiet, compact systems are mounted on wheels, and can be moved around the lab - or to another location - depending on current lab requirements.
AFS® E system users can choose from a number of options and accessories to match their specific requirements, including an online Total Organic Carbon (TOC) monitor, degassing option, and sanitary sampling valve, among others.
For more information, please visit www.merckmillipore.com/AFSE-large
Merck Millipore is the Life Science business of Merck and offers a broad range of innovative, performance products, services and business relationships that enable our customers' success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, Merck Millipore serves as a strategic partner to customers and helps advance the promise of life science. Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 66 countries and 2013 revenues of €2.6 billion. Merck Millipore operates as EMD Millipore in the U.S. and Canada.
For more information, please visit www.merckmillipore.com.
Merck is a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials. The company comprises six businesses – Merck Serono, Consumer Health, Allergopharma, Biosimilars, Merck Millipore and Performance Materials – and generated total revenues of € 11.1 billion in 2013. Around 39,000 Merck employees work in 66 countries to improve the quality of life for patients, to foster the success of customers and to help meet global challenges. Merck is the world's oldest pharmaceutical and chemical company – since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70% interest, the founding family remains the majority owner of the company to this day. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are Canada and the United States, where the company operates under EMD Serono, EMD Millipore and EMD Performance Materials.
Merck Millipore, the M mark, AFS, and Elix are registered trademarks of, and E.R.A. is a trademark of Merck KGaA. All other trademarks are the property of their respective owners.
Tel.: +1 (978) 715-46-70